The DOI matches its Crossref record; 136 of the 136 references it cites were found in a registry or an index.
The incidence and prevalence of psychiatric disorders in multiple sclerosis: A systematic review
Open accessAbstract
BACKGROUND: Psychiatric comorbidity is associated with lower quality of life, more fatigue, and reduced adherence to disease-modifying therapy in multiple sclerosis (MS). OBJECTIVES: The objectives of this review are to estimate the incidence and prevalence of selected comorbid psychiatric disorders in MS and evaluate the quality of included studies. METHODS: We searched the PubMed, PsychInfo, SCOPUS, and Web of Knowledge databases and reference lists of retrieved articles. Abstracts were screened for relevance by two independent reviewers, followed by full-text review. Data were abstracted by one reviewer, and verified by a second reviewer. Study quality was evaluated using a standardized tool. For population-based studies we assessed heterogeneity quantitatively using the I² statistic, and conducted meta-analyses. RESULTS: We included 118 studies in this review. Among population-based studies, the prevalence of anxiety was 21.9% (95% CI: 8.76%-35.0%), while it was 14.8% for alcohol abuse, 5.83% for bipolar disorder, 23.7% (95% CI: 17.4%-30.0%) for depression, 2.5% for substance abuse, and 4.3% (95% CI: 0%-10.3%) for psychosis. CONCLUSION: This review confirms that psychiatric comorbidity, particularly depression and anxiety, is common in MS. However, the incidence of psychiatric comorbidity remains understudied. Future comparisons across studies would be enhanced by developing a consistent approach to measuring psychiatric comorbidity, and reporting of age-, sex-, and ethnicity-specific estimates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A comprehensive systematic review of 118 studies on psychiatric comorbidities in MS found that psychiatric comorbidities were common; in particular, the prevalence of diagnosed anxiety and depression were estimated at 21.9 and 23.7%, respectively [53].”
From Functional neurological disorder and multiple sclerosis: a systematic review of misdiagnosis and clinical overlap (2022) · cites this paper as [53]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“MS patients show increased levels of anxiety and depression compared to healthy participants, and these conditions affect more than 20% of patients [8,21,22,23].”
From Biopsychosocial Correlates of Quality of Life in Multiple Sclerosis Patients (2022) · cites this paper as [23]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ferrari, A. J., Charlson, F. J., Norman, R. E., Patten, S. B., Freedman, G., Murray, C. J. L., Vos, T., & Whiteford, H. A. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001547 · Cited by 3,115
A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: Overview
Marrie, R., Cohen, J., Stüve, O., Trojano, M., Sørensen, P., Reingold, S., Cutter, G., & Reider, N. (2015) · Multiple Sclerosis · doi:10.1177/1352458514564491 · Cited by 762
Self-citationNeyeloff, J. L., Fuchs, S. C. P. C., & Moreira, L. B. (2012) · BMC Research Notes · doi:10.1186/1756-0500-5-52 · Cited by 731
Depressive disorders and immunity: 20 years of progress and discovery
Irwin, M. R., & Miller, A. H. (2007) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2007.01.010 · Cited by 676
Chwastiak, L., Ehde, D. M., Gibbons, L. E., Sullivan, M., Bowen, J. D., & Kraft, G. H. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.11.1862 · Cited by 555
Depression and multiple sclerosis
Sadovnick, A. D., Remick, R. A., Allen, J. B., Swartz, E. S., Yee, I. M. L., Eisen, K., Farquhar, R., Hashimoto, S. A., Hooge, J. P., Kastrukoff, L. F., et al. (1996) · Neurology · doi:10.1212/wnl.46.3.628 · Cited by 536
Quality of life in multiple sclerosis: the impact of depression, fatigue and disability
Amato, M. P., Ponziani, G., Rossi, F., Liedl, C. L., Stefanile, C., & Rossi, L. (2001) · Multiple Sclerosis Journal · doi:10.1177/135245850100700511 · Cited by 506
Quality of life in patients with multiple sclerosis
Janardhan, V., & Bakshi, R. (2002) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(02)00312-x · Cited by 489
Lobentanz, I. S., Asenbaum, S., Vass, K., Sauter, C., Klosch, G., Kollegger, H., Kristoferitsch, W., & Zeitlhofer, J. (2004) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2004.00257.x · Cited by 439
Anxiety disorders and their clinical correlates in multiple sclerosis patients
Korostil, M., & Feinstein, A. (2007) · Multiple Sclerosis Journal · doi:10.1177/1352458506071161 · Cited by 424
Cited by
Sorted by citations
Items 401–500 of 519
Late Onset Psychotic Depression in Multiple Sclerosis: A Case Report.
Taştekin, N., Kırşavoğlu, B., Yalçın, M., & Çetin, Ö. (2021) · Psychiatria Danubina · doi:10.24869/psyd.2021.574 · Cited by 1
Psychosocial Aspects of Rehabilitation in Neurodegenerative Diseases and Fields of Approach
Kaya, P. (2023) · Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry · doi:10.18863/pgy.1133369 · Cited by 1
Collins, C. R., & Marchioni, M. (2023) · Springer eBooks · doi:10.1007/978-3-031-20882-9_11 · Cited by 2
Reza, M., Cahill, J. F. X., Hungria, E. F., Stanton, L., Kritselis, M. A., Donahue, J. E., Sanborn, V. E., & Wu, C. (2023) · Advances in Psychiatry and Behavioral Health · doi:10.1016/j.ypsc.2023.04.001 · Cited by 1
COMORBIDITY OF MULTIPLE SCLEROSIS AND EPILEPSY: MORE QUESTIONS OR ANSWERS?
Maryenko, L. B., Litovchenko, T., Nehrych, T. I., & Florikian, V. A. (2023) · Proceedings of the Shevchenko Scientific Society Medical Sciences · doi:10.25040/ntsh2023.01.05 · Cited by 1
Epigenetics and multiple sclerosis
Kular, L., Castelo‐Branco, G., & Jagodic, M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-18516-8.00001-6 · Cited by 1
ESCLEROSE MÚLTIPLA - ABORDAGENS DIAGNÓSTICAS E TERAPÊUTICAS: UMA REVISÃO BIBLIOGRÁFICA
Bezerra, L. M. R., Yamashita, F. A., Pinho, J. L. L. F., Sobrinho, J., Rocha, C. C. S., Pires, C. B. R., Urzedo, G. O. Q., & Silva, C. D. M. (2024) · RECIMA21 - Revista Científica Multidisciplinar · doi:10.47820/recima21.v5i2.4950 · Cited by 1
Mood Disorder and Multimorbidity Complicating a Multiple Sclerosis Diagnosis
Krett, J. D., Riley, C., Zamvil, S. S., Goldman, M. D., Newsome, S. D., & Saidha, S. (2025) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000200376 · Cited by 1
Inflammation, Monoclonal Antibodies and Depression: Joining the Dots
Hunt, D. P. J. (2019) · Drug Safety · doi:10.1007/s40264-019-00819-0 · Cited by 1
Kalb, R. C., National Multiple Sclerosis Society, N. Y., Costello, K., National Multiple Sclerosis Society, N. Y., Guiod, L., & National Multiple Sclerosis Society, N. Y. (2019) · touchREVIEWS in Neurology · doi:10.17925/usn.2019.15.1.27 · Cited by 1
Effects of a Single Bout of Aquatic Exercise on Mood in Multiple Sclerosis
Genova, H. M., Dacosta‐Aguayo, R., Goverover, Y., Smith, A. D., Bober, C., & DeLuca, J. (2019) · International Journal of MS Care · doi:10.7224/1537-2073.2018-079 · Cited by 1
Krämer, J., & Meuth, S. G. (2021) · Neuromethods · doi:10.1007/978-1-0716-1213-2_21 · Cited by 1
The gateway reflex: breaking through the blood barriers
Murakami, K., Tanaka, Y., & Murakami, M. (2021) · International Immunology · doi:10.1093/intimm/dxab064 · Cited by 3
Prevalence of psychiatric disorders in multiple sclerosis patients: A cross-sectional study
Keshavarzi, A., Salimi, F., Mazdeh, M., Pirdehghan, A., & Ahmadpanah, M. (2021) · doi:10.32592/ajnpp.2022.9.2.105 · Cited by 1
Assessment of Biological Interactions Between Multiple Sclerosis Status and Depression for Mortality
Salter, A. R. (2021) · Neurology · doi:10.1212/wnl.0000000000012615 · Cited by 1
Smyth, P. S., Watson, K. E., Hamarneh, Y. N. A., & Tsuyuki, R. T. (2022) · Research Square · doi:10.21203/rs.3.rs-1386216/v1 · Cited by 1
Towards a phenotypic understanding of multiple sclerosis depression
Anderson, J., & Sumowski, J. F. (2023) · Multiple Sclerosis Journal · doi:10.1177/13524585221148143 · Cited by 1
Cavanna, A. E., & Carson, A. J. (2024) · Cambridge University Press eBooks · doi:10.1017/9781911623861.023 · Cited by 2
Zakibakhsh, N., Basharpoor, S., Langroodi, H. G., Narimani, M., Nitsche, M., & Salehinejad, M. A. (2024) · medRxiv · doi:10.1101/2024.05.19.24306880
Cognition, disease activity and MRI changes in early multiple sclerosis
Nygaard, G. O. (2016) · NORA - Norwegian Open Research Archives
Labormedizinische Diagnostik in der Psychiatrie
Schwarz, M. (2017) · Springer eBooks · doi:10.1007/978-3-662-49295-6_26
Rehabilitation in People with Progressive MS
Freeman, J. A. (2017) · Springer eBooks · doi:10.1007/978-3-319-65921-3_10
Modulating Microglial Activation As a Possible Therapeutic Target for Depression
Sato‐Kasai, M., Kato, T. A., Ohgidani, M., Horikawa, H., Mizoguchi, Y., Monji, A., & Kanba, S. (2017) · Springer eBooks · doi:10.1007/978-981-10-6580-4_18
Corpus callosum agenesis and clinically isolated syndrome (CIS): A case report
Moghadasi, A. N. (2018) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2018.11.017
Prefrontal gene expression changes in mood disorders and suicide
Zhao, J. (2018) · Data Archiving and Networked Services (DANS)
The Art of Living With Chronic Health Conditions
Miller, V. J., Nahar, S., Praetorius, R. T., & Rivedal, J. (2019) · Illness Crisis & Loss · doi:10.1177/1054137319857088
Catarino, B. M., Finkelsztejn, A., Aranchipe, M. D. S., Ramos, J. G. L., Rodrigues, L. P., & Paiva, L. L. (2019) · Clinical & Biomedical Research · doi:10.22491/2357-9730.92288
Interleukin 1 Beta Is Associated With Depression in Multiple Sclerosis PatientsPreprint
Aguilar-Talamantes, H., Islas‐Hernández, A., Rodríguez-Castañeda, A., Bertado-Cortés, B., Corlay-Noriega, I. S. Y., & Garcia-delaTorre, P. (2021) · Research Square · doi:10.21203/rs.3.rs-173017/v1
Особливості депресивних розладів у хворих на розсіяний склероз
Nehrych, T. I., & Kyryliuk, S. Y. (2020) · Izdevniecība “Baltija Publishing” eBooks · doi:10.30525/978-9934-26-024-7-11
Reforma trabalhista e trabalho digno: uma combinação possível?
Rafagnin, M. S. S., & Nogueira, V. M. R. (2021) · Argumentum · doi:10.47456/argumentum.v13i1.28978
(2021) · Elsevier eBooks · doi:10.1016/b978-3-437-22085-2.00028-8
Multiple Sclerosis and Telerehabilitation
Backus, D. A., Ehde, D. M., & Wallin, M. T. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-82486-6.00009-5
The bipolarity of Alberto Santos-Dumont: flights and falls of the “Father of Aviation”
Cheniaux, E. (2022) · Jornal Brasileiro de Psiquiatria · doi:10.1590/0047-2085000000364
Veauthier, C., & Paul, F. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813014-8.00016-0
Interleukin 1 beta is associated with depression in Multiple Sclerosis patientsPreprint
Aguilar-Talamantes, H., Islas‐Hernández, A., Rodríguez-Castañeda, A., Bertado-Cortés, B., Corlay-Noriega, I. S. Y., & Garcia-delaTorre, P. (2020) · medRxiv · doi:10.1101/2020.12.11.20245472
Labormedizinische Diagnostik in der Psychiatrie
Schwarz, M. (2016) · Springer eBooks · doi:10.1007/978-3-642-45028-0_26-1
Differenzialdiagnose psychotischer Symptome
Falkai, P., Hasan, A., & Röh, A. (2016) · PSYCH up2date · doi:10.1055/s-0042-105450
Refaie, E., García, S. G., Martínez‐Domínguez, S. J., Gargallo-Puyuelo, C. J., Quilez, L. L., Carrera‐Lasfuentes, P., Arroyo, M., & García, F. G. (2022) · Gastroenterología y Hepatología (English Edition) · doi:10.1016/j.gastre.2021.03.012
Depression as a determinant of quality of life in patients with multiple sclerosis
Stojanov, A., & Stojanov, J. (2022) · Galenika Medical Journal · doi:10.5937/galmed2203023s
Tsuda, H. (2022) · Equilibrium Research · doi:10.3757/jser.81.173
Sgoifo, A., Marazzi, M. R., Susani, E. L., Saraceno, L., Esposito, M. G., Campagna, C., Agostoni, E. C., & Protti, A. (2022) · Journal of Neurological Research And Therapy · doi:10.14302/issn.2470-5020.jnrt-22-4106
Arnett, P. A., & Cadden, M. H. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91497-0.00234-4
Personality Factors and Motivation
Filser, M., & Penner, I. (2023) · Springer eBooks · doi:10.1007/978-3-031-13498-2_7
О.Д., П. О. О. Ш. (2022) · Український медичний часопис · doi:10.32471/umj.1680-3051.152.236002
Evaluating a Tree of Life group for individuals with Multiple Sclerosis
Coppock, C., Adlington, R., Fisher, K., & MacCormack, M. (2019) · Health Psychology Update · doi:10.53841/bpshpu.2019.28.1.4
Understanding others is knowledge, understanding oneself is enlightenment
Castro, J. P., & Zeitelhofer, M. (2023) · Annals of Palliative Medicine · doi:10.21037/apm-22-1443
Sağıcı, Ö., Karakaş, H., & Kaya, E. (2023) · Journal of Multiple Sclerosis Research · doi:10.4274/jmsr.galenos.2023.2022-12-1
(2021) · Romanian Journal of Psychiatry & Psychotherapy · doi:10.37897/rjpp.2021.1.4
Barbilian, A., Barbu, R. E., & Prelipceanu, D. (2016) · Romanian Journal of Psychiatry & Psychotherapy · doi:10.37897/rjpp.2016.3.9
Baravi, H. (2023) · Journal of Advances in Medicine and Medical Research · doi:10.9734/jammr/2023/v35i195159
Photobiomodulation Therapy for Other Brain-Related Disorders
Salehpour, F., Sadigh‐Eteghad, S., Mahmoudi, J., Kamari, F., Cassano, P., & Hamblin, M. R. (2023) · Synthesis lectures on biomedical engineering · doi:10.1007/978-3-031-36231-6_14
Uso de fármacos antidepresivos en neurología
García-Alberca, J. M. (2023) · Kranion · doi:10.24875/kranion.m23000058
Mental health and multiple sclerosis: how much are your patients sharing with you?
Winchester, C. (2023) · British Journal of Neuroscience Nursing · doi:10.12968/bjnn.2023.19.5.190
Investigating the Link Between Anxiety and Multiple Sclerosis: A ReviewPreprint
Mohammed, E. M. A. (2023) · Research Square · doi:10.21203/rs.3.rs-3542372/v1
Mejía, M. D. L. Á., & Araujo, P. (2023) · International Journal of Family Medicine & Healthcare · doi:10.33425/2833-0382.1010
Cognitive impairment in multiple sclerosis
Sriwastava, S., Beard, K., Srivastava, S., Jaiswal, S., & Seraji‐Bozorgzad, N. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95343-6.00010-8
Qualification and predictors of the development of affective disorders in multiple sclerosi
Glushchenko, E. I., GUBSKAIA, K. V., Sinitsyna, L. V., & Malygin, Y. V. (2024) · Vestnik nevrologii psihiatrii i nejrohirurgii (Bulletin of Neurology Psychiatry and Neurosurgery) · doi:10.33920/med-01-2401-12
", F. S. B. E. I. O. H. E., Zimina, P. A., GUBSKAIA, K. V., Sinitsyna, L. V., Malygin, Y. V., & Akhpashev, A. A. (2024) · Vestnik nevrologii psihiatrii i nejrohirurgii (Bulletin of Neurology Psychiatry and Neurosurgery) · doi:10.33920/med-01-2402-03
Neuropsychiatric Manifestations in Multiple Sclerosis and Other Demyelinating Diseases
Kwon, Y. N. (2024) · Springer eBooks · doi:10.1007/978-981-97-1821-4_18
Bućma, T., Sladojević, I., Arambašić, L. T., Jeremić, N., & Tomić, B. (2024) · Medicina · doi:10.3390/medicina60060941
Makarov, C., Donnachie, E., Hapfelmeier, A., Hemmer, B., & Gasperi, C. (2025) · Multiple Sclerosis Journal - Experimental Translational and Clinical · doi:10.1177/20552173251315458
Psychiatrie et sclérose en plaques : l’œuf ou la poule ?
Heinzlef, O. (2025) · Pratique Neurologique - FMC · doi:10.1016/j.praneu.2025.01.012
GUBSKAIA, K. V., Malygin, Y. V., Худяков, А. В., & Odnorob, E. N. (2025) · Neurology Bulletin · doi:10.17816/nb641670
Shen, Y. C., Xiang, W., Xiong, Q., Luo, S., Chen, X., Song, Z., Qiu, Y., Pang, L., & Hong, D. (2025) · Neurological Research · doi:10.1080/01616412.2025.2534082
Experience with the use of sampeginterferon beta-1a in real clinical practice in the Moscow region
Peshkin, A. N., Lizhdvoy, V. Y., Kotov, S. V., & Sutormin, M. V. (2025) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2025-4-50-54
Skinfold thickness in Ukrainian men and women with multiple sclerosis
Gunas, M. М. (2025) · Reports of Vinnytsia National Medical University · doi:10.31393/reports-vnmedical-2025-29(3)-01
Phillips, B., Singh, H., Morcos, M., Golrokhian‐Sani, A., Morcos, M., & Fu, R. (2025) · Healthcare · doi:10.3390/healthcare13202593
Psychiatric morbidity during the multiple sclerosis prodrome is associated with future disability
Chertcoff, A. S., Ruiz‐Algueró, M., Yusuf, F. L. A., Zhao, Y., Zhu, F., Marrie, R. A., & Tremlett, H. L. (2025) · Multiple Sclerosis Journal · doi:10.1177/13524585251382801
Self-citationMotl, R. W., Bombardier, C. H., Duffecy, J. L., Hibner, B. A., Wathen, A., Carrithers, M., & Cutter, G. (2024) · Figshare · doi:10.6084/m9.figshare.25632897
Self-citationSmyth, P. S., Watson, K. E., Hamarneh, Y. N. A., & Tsuyuki, R. T. (2022) · Figshare · doi:10.6084/m9.figshare.20372726
Smyth, P. S., Watson, K. E., & Tsuyuki, R. T. (2021) · Figshare · doi:10.6084/m9.figshare.16960222
Smyth, P. S., Watson, K. E., & Tsuyuki, R. T. (2021) · Figshare · doi:10.6084/m9.figshare.16960219
Smyth, P. S., Watson, K. E., & Tsuyuki, R. T. (2021) · Figshare · doi:10.6084/m9.figshare.16960216
Kremer, I., Jongen, P. J., Evers, S., Hoogervorst, E. L. J., Verhagen, W. I. M., & Hiligsmann, M. (2021) · Figshare · doi:10.6084/m9.figshare.14396706
Kremer, I., Jongen, P. J., Evers, S., Hoogervorst, E. L. J., Verhagen, W. I. M., & Hiligsmann, M. (2021) · Figshare · doi:10.6084/m9.figshare.14396712
Smyth, P. S., Watson, K. E., & Tsuyuki, R. T. (2021) · Figshare · doi:10.6084/m9.figshare.16960213
Kremer, I., Jongen, P. J., Evers, S., Hoogervorst, E. L. J., Verhagen, W. I. M., & Hiligsmann, M. (2021) · Figshare · doi:10.6084/m9.figshare.14396709
Zakibakhsh, N., Basharpoor, S., Langroodi, H. G., Narimani, M., Nitsche, M. A., & Salehinejad, M. A. (2024) · Figshare · doi:10.6084/m9.figshare.27019241
Hassan, S. S., Darwish, E. S., Ahmed, G. K., Azmy, S. R., & Haridy, N. A. (2024) · Figshare · doi:10.6084/m9.figshare.26607688
Li, Z., Chen, K., Shao, Q., Lu, H., Zhang, X., Pu, Y., Sun, X., He, H., & Cao, L. (2024) · Figshare · doi:10.6084/m9.figshare.26564853
Albishi, A. M., Alshammari, Z. S., Almhawas, S. S., Alimam, D. M., Alosaimi, M. H., & Aljarallah, S. (2026) · Healthcare · doi:10.3390/healthcare14030285
Marrie, R. A., Maxwell, C. J., Bolton, J. M., Söderling, J. K., Bernstein, C. N., Krysko, K. M., McKay, K. A., Rotstein, D., Deakin-Harb, K., & Razaz, N. (2026) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2026.107041
Self-citationBaghbanian, S. M., Gharanjik, A., Ghazaeian, M., Bakhshi, A., & Hosseinnataj, A. (2026) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2026.107075
Wang, P.-C., Chen, K.-E., Lin, H.-A., & Lin, S. F. (2026) · Osteoporosis International · doi:10.1007/s00198-026-07887-w
Dang, P. L., Krug, I., & Kiropoulos, L. A. (2026) · Cognitive Therapy and Research · doi:10.1007/s10608-026-10722-5
Can Blood Flow Restriction Training Improve Mental Health and Quality of Life in Multiple Sclerosis?
Cano-Sánchez, J., Aibar‐Almazán, A., Hita‐Contreras, F., Castellote‐Caballero, Y., & Carcelén‐Fraile, M. D. C. (2026) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2026.02.488
Multivariate Model of Bipolar Disorder Predictors in Multiple Sclerosis: a Longitudinal Study
GUBSKAIA, K. V., Malygin, Y. V., & Alexandrova, A. Y. (2026) · Psikhiatriya · doi:10.30629/2618-6667-2026-24-1-17-23
Physiopathologie et traitement de la fatigue dans la sclérose en plaques
Chalah, M. A. (2019) · theses.fr (ABES) · doi:10.70675/9be71a74z7578z4637za069zf44a656eb777
Royer, N. (2022) · theses.fr (ABES) · doi:10.70675/f339adbaz4521z4a94zad19z62ea83348e19
GUBSKAIA, K. V., & Malygin, Y. V. (2026) · Vestnik nevrologii psihiatrii i nejrohirurgii (Bulletin of Neurology Psychiatry and Neurosurgery) · doi:10.33920/med-01-2603-06
Bazmi, E., Behnoush, A. H., Lapevandani, M. M., Talebian, M. T., Jahani, S., & Sahraian, M. A. (2026) · Health Science Reports · doi:10.1002/hsr2.72331
Laborchemische Diagnostik, Biomarker
Schwarz, M., Wiltfang, J., & Hansen, N. (2026) · Springer Reference Medizin · doi:10.1007/978-3-642-45028-0_26-2
Radfar, F., Shahidi, S., Farahani, H., Moghadasi, A. N., & Eskandrieh, S. (2026) · The Clinical Neuropsychologist · doi:10.1080/13854046.2026.2659074
Large language models to infer depression in patients with neurological conditions
Julian-Kwong, M., Poole, S., Henderson, K., Wijangco, J., Sisodia, N., Gelfand, J. M., Guo, C., & Bove, R. M. (2026) · BMJ Neurology Open · doi:10.1136/bmjno-2025-001502
Šilić, P., & Motl, R. W. (2026) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2026.107273
Knowles, L. M., Mistretta, E. G., Umucu, E., Arellano, D., Williams, M., & Lee, B. (2026) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2026.107270
Metadata
- Authors
- Marrie, R. A., Reingold, S., Cohen, J., Stuve, O., Trojano, M., Sorensen, P. S., Cutter, G., & Reider, N.
- Affiliations
- University of Manitoba (CA)
- Scientific and Clinical Review Associates, LLC, USA
- Cleveland Clinic (US)
- Department of Neurology and Neurotherapeutics, University of Texas Southwestern, USA
- Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari, Italy
- Department of Neurology, Copenhagen University Hospital Rigshospitalet, Denmark
- University of Alabama at Birmingham (US)
- Corresponding author
- Marrie, Ruth Ann
- Venue
- Multiple Sclerosis Journal
- Publisher
- SAGE Publications
- Published
- 2015-01-12
- Volume
- 21
- Issue
- 3
- Pages
- 305-317
- ISSN
- 1352-4585 (ISSN-L)
- 1477-0970
- PMC
- PMC4429164
- OpenAlex
- W2105913548
- Cited by
- 519
- References
- 136
- Citations by year
- 2026: 42 · 2025: 31 · 2024: 45 · 2023: 46 · 2022: 52 · 2021: 68 · 2020: 48 · 2019: 38 · 2018: 43 · 2017: 47 · 2016: 43 · 2015: 16
- FWCI
- 7.28
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Multiple Sclerosis Journal (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, other-oa)
- mediaTUM (Technical University of Munich) (submittedVersion)
- CINECA IRIS Institutional Research Information System (University of Bari Aldo Moro) (submittedVersion)
- Funders
- U.S. Department of Defense
- National Multiple Sclerosis Society
- Pfizer
- GlaxoSmithKline
- Sanofi
- Gilead Sciences
- Biogen
- Teva Pharmaceutical Industries
- Cleveland Clinic
- Multiple Sclerosis Society of Canada
- Multiple Sclerosis Society
- MedDay Pharmaceuticals
- National Institutes of Health
- Genentech
- EMD Serono
- National Heart, Lung, and Blood Institute
- National Institute of Neurological Disorders and Stroke
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Keywords
- multiple sclerosis, psychiatric comorbidity, depression, anxiety, alcohol abuse, bipolar disorder, substance abuse, psychosis, incidence, prevalence, quality of life, fatigue
- MeSH terms
- Mental Disorders, Humans, Multiple Sclerosis, Comorbidity, Incidence, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
